<DOC>
	<DOC>NCT00713674</DOC>
	<brief_summary>The purpose of this study is to examine treatment method of Methicillin-resistant Staphylococcus aureus (MRSA) decolonization in patients.</brief_summary>
	<brief_title>Comparison of Decolonization of Methicillin-resistant Staphylococcus Aureus (MRSA) Using Theraworx</brief_title>
	<detailed_description>Decolonization therapy is indicated for management of patients with MRSA. Theraworx is reported to be an effective antimicrobial against multiple organisms. In this study, patients with positive MRSA colonization culture will be treated with Theraworx to evaluate decolonization duration capability.</detailed_description>
	<mesh_term>Staphylococcal Infections</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Methicillin</mesh_term>
	<mesh_term>Mupirocin</mesh_term>
	<mesh_term>Antibiotics, Antitubercular</mesh_term>
	<mesh_term>Allantoin</mesh_term>
	<criteria>Positive MRSA culture Patients currently on or start antibiotic therapy directed for MRSA.(Prophylaxis antibiotic for surgical procedure not considered therapy.) Patients with MRSA infected wounds Patients under the age of 18 years A woman currently pregnant or nursing a child Patients participating in another study within 30 days of randomization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Methicillin resistance</keyword>
</DOC>